FDA Revokes Approval for Preterm Birth Drug Makena

被引：2
|
作者：
Harris, Emily
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 17期
关键词：
D O I：
10.1001/jama.2023.6257
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1444 / 1444
页数：1
相关论文
共 50 条
  • [21] Drug approval: Future aspects of the FDA
    Skelly, JP
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1998, 20 (06): : 527 - 537
  • [22] Overview of FDA Drug Approval and Labeling
    Clarridge, Katherine E.
    Chin, Stacy J.
    Stone, Kelly D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3051 - 3056
  • [23] FDA to slash drug approval times
    不详
    CHEMISTRY & INDUSTRY, 2003, (13) : 5 - 5
  • [24] FDA accelerates drug approval system
    Scott, A
    CHEMICAL WEEK, 2004, 166 (32) : 42 - 42
  • [25] 17 α-Hydroxyprogesterone Caproate (Makena®)A Guide to Its Use in the Prevention of Preterm Birth
    Mary Hines
    Katherine A. Lyseng-Williamson
    Emma D. Deeks
    Clinical Drug Investigation, 2013, 33 : 223 - 227
  • [26] FDA REVOKES SAFE AND SUITABLE DAIRY INGREDIENTS
    不详
    AMERICAN DAIRY REVIEW, 1978, 40 (03): : 58 - 58
  • [27] FDA shortened drug approval time in 1995
    不详
    PUBLIC HEALTH REPORTS, 1996, 111 (04) : 290 - 290
  • [28] 2004 Drug Approval Highlights FDA Update
    Laustsen, Gary
    Wimmett, Lynn
    NURSE PRACTITIONER, 2005, 30 (02): : 14 - 16
  • [29] FDA drug approval summaries:: Pemetrexed (Alimta®)
    Hazarika, M
    White, RM
    Johnson, JR
    Pazdur, R
    ONCOLOGIST, 2004, 9 (05): : 482 - 488
  • [30] FDA drug approval summary:: Panitumumab (Vectibix™)
    Giusti, Ruthann M.
    Shastri, Kaushikkumar A.
    Cohen, Martin H.
    Keegan, Patricia
    Pazdur, Richard
    ONCOLOGIST, 2007, 12 (05): : 577 - 583
12345